ÂÜŔňÂŇÂ×

Thomas Busby is a Senior Vice President at Outcome Capital, having joined the Firm in 2015. With transactional experience spanning the breadth of life science verticals, Thom’s primary coverage and focus spans the medical device, digital health, and life sciences services segments. In this capacity, Thom has advised dozens of management teams on a variety of complex strategic issues ranging from transaction process considerations to valuation and transaction structure maximization, to value proposition communication and buyer analysis, along with the plethora of managerial challenges faced in executing complex corporate events. Devoted to the industry he serves, Thom has been published in leading industry publications, including: MedTech Strategist, Life Science Leader, and The Pharma Letter. Thom has also served as a panelist and moderator for numerous industry events and is a Board Member of HealthTech Build, a Boston-based digital health innovation group.

Prior to his career in investment banking, Thom pursued his passion for the public service and non-profit sectors. He raised significant capital for many education-related ventures while holding management and leadership positions. At one time, he also held a Massachusetts teaching license.

Thom completed his MBA at Suffolk University on full academic scholarship. He was voted president of the School’s business association and served as class speaker. Prior, he completed a BS in Philosophy at Suffolk’s Honors college. Committed to giving back, Thom served as a two-term President for the University’s Alumni Board of Directors. Thom is a FINRA Registered Securities Representative holding his Series 79 and 63.